TCG Crossover Management, LLC Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$875.5B
Holdings
38
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (38 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CGONCG ONCOLOGY INC | 3,670,206 | $95.4B | 10.90% | |
| 2 | TNGXTANGO THERAPEUTICS INC | 10,736,000 | $55.0B | 6.28% | |
| 3 | COGTCOGENT BIOSCIENCES INC | 6,964,375 | $50.0B | 5.71% | |
| 4 | OCULOCULAR THERAPEUTIX INC | 5,319,148 | $49.4B | 5.64% | |
| 5 | CDTXCIDARA THERAPEUTICS INC | 1,005,901 | $49.0B | 5.60% | |
| 6 | ABVXABIVAX SA AMERICAN DEPOSITARY SHARES | 6,056,596 | $46.3B | 5.29% | |
| 7 | AMLXAMYLYX PHARMACEUTICALS INC | 5,943,812 | $38.1B | 4.35% | |
| 8 | CNTACENTESSA PHARMACEUTICALS PLC | 2,890,816 | $38.0B | 4.34% | |
| 9 | FULCFULCRUM THERAPEUTICS INC | 5,250,000 | $36.1B | 4.13% | |
| 10 | DYNDYNE THERAPEUTICS INC | 3,766,660 | $35.9B | 4.10% | |
| 11 | EYPTEYEPOINT PHARMACEUTICALS INC | 3,572,335 | $33.6B | 3.84% | |
| 12 | UPBUPSTREAM BIO INC | 2,801,763 | $30.8B | 3.51% | |
| 13 | YB4PSAVARA INC | 12,362,205 | $28.2B | 3.22% | |
| 14 | DNTHDIANTHUS THERAPEUTICS INC | 1,501,624 | $28.0B | 3.20% | |
| 15 | TYRATYRA BIOSCIENCES INC | 2,898,103 | $27.7B | 3.17% | |
| 16 | IRONDISC MEDICINE INC | 465,257 | $24.6B | 2.81% | |
| 17 | TRMLTOURMALINE BIO INC | 1,477,593 | $23.6B | 2.70% | |
| 18 | AGIOAgios Pharmaceuticals, Inc. | 697,003 | $23.2B | 2.65% | |
| 19 | GPCRSTRUCTURE THERAPEUTICS INC | 1,063,000 | $22.0B | 2.52% | |
| 20 | XNCRXENCOR INC | 2,452,138 | $19.3B | 2.20% | |
| 21 | SLNSILENCE THERAPEUTICS PLC | 3,033,560 | $17.6B | 2.01% | |
| 22 | SLNOSOLENO THERAPEUTICS INC | 186,250 | $15.6B | 1.78% | |
| 23 | CATBUSDASTRIA THERAPEUTICS INC | 2,761,861 | $14.8B | 1.69% | |
| 24 | RAPTRAPT Therapeutics, Inc. | 1,636,275 | $13.1B | 1.50% | |
| 25 | THRDTHIRD HARMONIC BIO INC | 1,915,424 | $10.4B | 1.19% | |
| 26 | ELVNEnliven Therapeutics, Inc. | 498,000 | $10.0B | 1.14% | |
| 27 | MBXMBX BIOSCIENCES INC | 650,000 | $7.4B | 0.85% | |
| 28 | NKTRNEKTAR THERAPEUTICS | 266,666 | $6.9B | 0.79% | |
| 29 | VTGNVISTAGEN THERAPEUTICS INC | 2,676,580 | $5.4B | 0.61% | |
| 30 | KODKODIAK SCIENCES INC | 1,145,538 | $4.3B | 0.49% | |
| 31 | KURAKURA ONCOLOGY INC | 735,184 | $4.2B | 0.48% | |
| 32 | TRDAENTRADA THERAPEUTICS INC | 584,955 | $3.9B | 0.45% | |
| 33 | AVU0ADVERUM BIOTECHNOLOGIES INC | 1,796,482 | $3.9B | 0.44% | |
| 34 | AVTXAVALO THERAPEUTICS INC | 483,000 | $2.4B | 0.28% | |
| 35 | VTYXVENTYX BIOSCIENCES INC | 316,195 | $676.7M | 0.08% | |
| 36 | JBIOJADE BIOSCIENCES INC | 64,023 | $639.6M | 0.07% | |
| 37 | CABACABALETTA BIO INC | 86,795 | $131.9M | 0.02% | |
| 38 | KROSKEROS THERAPEUTICS INC | 0 | $0 | 0.00% |